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PENGENALPASTIAN PROTEIN ANTIGENIK Helicobacter pylori DARIPADA 
ISOLAT PESAKIT YANG ADA PATOLOGI GASTRIK  
ABSTRAK   
Helicobacter pylori ialah bakteria gram negatif, berbentuk spiral, mikroaerofil, yang 
berkolonisasi pada bahagian atas apikal sel epitel perut dan lapisan mukosa manusia. 
Jangkitan H. pylori telah dikaitkan dengan pelbagai penyakit gastrik dengan spektrum 
klinikal yang luas, daripada kanser perut hingga ulser pada saluran pencernaan. 
Patogenisiti jangkitan bergantung pada virulens strain, kerentanan hos dan faktor 
persekitaran. Dengan itu, adalah sangat penting untuk memahami patogenesis penyakit 
ini. Kajian untuk mengenal pasti  protein antigenik H. pylori memungkinkan  
pembangunan ujian diagnostik bagi patogen ini. 
Beberapa media telah dinilai untuk tujuan mengisolasi dan mengkultur H. 
pylori. Tiga isolat klinikal digunakan, dan H. pylori ATCC 700824 merupakan strain 
rujukan. Untuk medium cecair, medium Infusi Otak Jantung (‘Brain Heart Infuison’) 
dan medium Tryptic Soya dengan 10% serum janin lembu diuji untuk mengenal pasti 
medium yang memberikan pertumbuhan mikrob yang lebih tinggi (cfu). Sementara itu, 
perbandingan antara medium pepejal yang dilengkapi dengan serum atau darah iaitu 
Agar Tryptic Soya  (TSA), Agar Columbia, Agar Eugon dan Agar Infusi Otak dan 
Jantung (BHIA), menunjukkan bahawa medium dengan suplemen darah memberikan 
cfu lebih tinggi. Medium komersial, TSA dengan 5% darah  biri-biri, telah 
menghasilkan pertumbuhan terbaik antara medium pepejal yang diuji.  
xxii 
 
Dalam kajian ini, biopsi sampel perut adalah daripada pesakit yang telah 
menjalani skop Kerongkong-Gastro-Duodenal (Esophageal-Gastro-Duodenal). 
Daripada 564 sampel biopsi yang diperoleh; 50 isolat H. pylori telah berjaya diisolasi 
daripada pesakit dengan pelbagai patologi gastrik. Keputusan penyaringan PCR 
menunjukkan bahawa semua isolat adalah positif bagi gen Ure C, sedangkan hanya 42 
isolat yang positif untuk gen Cag A. 
Satu ‘in-house’ anti-H. pylori ESA-IgG ELISA telah dibangunkan dan 
dibandingkan dengan kit komersil, iaitu EIAgen H. pylori IgG (Adaltis, Itali) dan 
keputusannya menunjukkan bahawa sensitiviti dan spesifisiti kedua ujian adalah sama. 
Empat kumpulan sampel serum digunakan, ia berdasarkan kepada keputusan  kultur 
biopsi dan ‘in-house’ H. pylori IgG-ELISA: Kumpulan I: kultur positif dan seropositif; 
Kumpulan 2: kultur negatif dan seronegatif; Kumpulan 3: sihat dan seronegatif, dan 
Kumpulan 4: penyakit lain dan seronegatif. Tiga isolat yang berbeza yang berasal 
daripada patologi gastrik yang berbeza telah digunakan untuk ekstrasi protein, iaitu 
SJI002 dari gastroduodenitis, SJI016 dari ulser perut, dan SJI017 dari ulser duodenum. 
Dua penyediaan protein digunakan iaitu Antigen Ekskretori Sekretori (ESA) dan 
Antigen Perkaitan Permukaan (SAA). SDS-PAGE dan blot Western telah dijalankan 
ke atas ESA dan SSA, dengan menggunakan sampel serum yang dinyatakan di atas. 
Satu siri jalur antigenik telah dikenal pasti sebagai protein yang mempunyai 
potensi diagnostik. Dengan menggunakan sediaan ESA, tiga jalur dikenal pasti 
daripada isolat SJI002 iaitu 17 kDa, 29 kDa  dan 57 kDa. Daripada isolat SJI016, 
empat jalur dikenal pasti iaitu 13 kDa, 17 kDa, 29 kDa dan 41 kDa, dan daripada isolat 
SIJ017 tiga jalur telah dikenal pasti iaitu 13 kDa, 17 kDa dan 50 kDa. Dengan 
xxiii 
 
menggunakan sediaan SAA, tiga jalur antigenik dikenal pasti daripada isolat SJI002 
dan SJ1016 iaitu 13 kDa, 29 kDa dan 57 kDa. Manakala daripada isolat SIJ017, empat 
jalur dikenal pasti iaitu 13 kDa, 17 kDa, 29 kDa dan 57 kDa. Daripada keputusan yang 
diperolehi, dapat dilihat terdapat jalur antigenik yang dikongsi antara sediaan antigen 
dan antara isolat. Kajian ini telah berjaya mengenal pasti panel jalur antigenik yang 
berpotensi untuk digunakan bagi pembangunan ujian diagnostik bagi jangkitan H. 
pylori pada masa hadapan. Oleh sebab isolat yang digunakan adalah daripada pesakit 
tempatan, antigen yang dihasilkan dijangka sesuai untuk digunakan bagi mendiagnos 
pesakit di Malaysia. 
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IDENTIFICATION OF Helicobacter pylori ANTIGENIC PROTEINS FROM 
ISOLATES OF PATIENTS WITH GASTRIC PATHOLOGIES 
 
ABSTRACT 
Helicobacter pylori is a gram negative, spiral-shaped, microaerophilic bacterium, which 
colonizes the apical side of human gastric epithelial cells and mucous layer. H. pylori 
infections are associated with various gastric diseases with wide spectrum of clinical 
outcomes, ranging from gastric cancer to ulceration of the gastrointestinal tract. The 
pathogenicity of the infection depends on the strain virulence, host susceptibility and 
environmental co-factors.  Thus it is very important to understand the pathogenesis of the 
disease. Identification of the antigenic proteins of H. pylori, may eventually lead to the 
development of diagnostic test for this pathogen.   
Several media were evaluated for isolation and propagation of H. pylori. Three 
clinical isolates were used and ATCC 700824 strain were employed as reference.  For 
liquid medium, Brain Heart Infusion broth and Tryptic Soy broth with 10% fetal bovine 
serum were tested and the former was found to give higher microbial growth (cfu). 
Meanwhile comparisons between serum or blood supplemented solid media i.e. Tryptic 
Soy Agar (TSA), Columbia Agar, Eugon Agar and Brain Heart Infusion Agar (BHIA), 
showed that the media with blood supplement gave higher cfu. The conventional agar 
medium, TSA with 5% defibrinated sheep blood, produced the best growth among the 
solid media. 
In this study, stomach biopsy samples were from the patients who underwent 
Esophageal-Gastro-Duodenal scope. Out of 564 biopsy samples, 50 isolates of H. pylori 
xxv 
 
were successfully isolated from patients with various gastric pathologies. PCR screening 
showed that all isolates were positive for Ure C gene, whereas only 42 isolates were 
positive for Cag A gene.   
An in-house anti-H. pylori ESA-IgG ELISA was developed and compared with a 
commercially available EIAgen H. pylori IgG kit (Adaltis, Italy) and the results showed 
similar sensitivities and specificities. Four groups of serum samples were used, they were 
categorised according to the results of biopsy culture and the in-house IgG-ELISA: 
Group I: culture positive and seropositive; Group 2: culture negative and seronegative; 
Group 3: healthy and seronegative, and Group 4: patients with other diseases and 
seronegative. Three different isolates which originated from different gastric pathologies 
were used for protein preparation, namely SJI002 from gastroduodenitis, SJI016 from 
gastric ulcer, and SJI017 from duodenal ulcer. Two different protein preparations were 
used i.e. Excretory Secretory Antigen (ESA) and Surface Associated Antigen (SAA). 
ESA and SAA were then subjected to SDS-PAGE and Western blot analysis using the 
above serum samples. 
A series of antigenic bands were identified as proteins with potential diagnostic value.  
For ESA, three bands were identified from isolate SJI002 namely 17 kDa, 29 kDa and 
57 kDa. From isolate SJI016, four bands were identified namely 13 kDa, 17 kDa, 29 
kDa and 41 kDa; and from isolate SIJ017 three bands were identified namely 13 kDa, 
17 kDa and 50 kDa.  Using SAA three antigenic bands were identified from isolates 
SJI002 & SJI016 i.e 13 kDa, 29 kDa and 57 kDa. From isolate SIJ017, four bands 
were identified i.e 13 kDa, 17 kDa, 29 kDa and 57 kDa. As can be observed there 
were some common bands between the antigen preparations and among the isolates. 
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Thus this study has successfully identified a panel of antigenic bands that are 
potentially very useful for future development of diagnostic test for H. pylori infection. 
Since these isolates were from local patients, the antigens derived from them would be 
very suitable to be used for diagnosis and screening of Malaysian Patients. 
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CHAPTER 1 
INTRODUCTION 
1.1 General introduction  
 
Helicobacter pylori is a gram negative, spiral-shaped, micro-aerophilic, 
flagellated slow growing bacteria. It colonizes the apical side of human gastric 
epithelial cells and mucous layer (Benoit et al., 2004). It was  first isolated in 1982 by 
Marshall and Warren, and found to be probably the most chronic bacterial infection of 
mankind (Rieder et al., 2005), infecting almost half of the human population 
especially in developing countries (Malaty, 2007). H. pylori infections are associated 
with various gastric diseases; among them the most common is gastritis, and is also 
implicated in more severe gastric diseases including chronic atrophic gastritis (a 
precursor of gastric carcinomas), peptic ulceration, duodenal ulcer and mucosa-
associated lymphoid tissue lymphomas (Jungblut et al., 2000). The bacterium was also 
classified as class I carcinogen by the World Health Organization (Frenck and 
Clemens, 2003) after a few studies proved that it has the capability to cause and 
induce gastric carcinoma in animal models (Giannakis et al., 2008). H. pylori  is also 
associated with some other associated diseases apart from gastric pathologies  such as 
asthma (Franceschi and Gasbarrini, 2007), atherosclerotic heart disease (Franceschi 
and Gasbarrini, 2007). Consequently the early identification/detection and treatment of 
H. pylori infection can prevent or reduce morbidity and mortality rates of patients 
(Chisholm and Owen, 2008). 
There is a wide spectrum of clinical outcomes induced by chronic gastritis 
caused by H. pylori, ranging from ulceration to gastric cancer of the gastrointestinal 
2 
 
tract. The severity of the infection depends on the strain virulence, host susceptibility 
and environmental co-factors. Some of the infected patients are symptomatic, whereas, 
some will remain asymptomatic for life (Malaty, 2007). However, 6-20% of the 
infected individuals tend to develop duodenal ulceration and a small proportion of 
them will eventually advance to gastric cancer. Nevertheless, duodenal ulcer and 
gastric cancer vary greatly in their symptoms and pathology, hence, the differences in 
pathogenesis is a major factor that greatly governs the different patterns of gastritis 
(Lochhead and El-Omar, 2007). In view of the fact of H. pylori infection can cause 
such serious diseases, it is very important to understand the pathogenesis of the 
disease with the intention for identifying those patients which are at high risk of 
developing cancer (Brooks et al., 2004). During the process of H. pylori infection, the 
antigens secreted from the bacterium elicit strong humoral immune responses which 
are characterized by the infiltration of the mucosa layer by neutrophiles, lymphocytes 
and macrophages. These antigens can thus be regarded as prospective candidates that 
may serve as infection biomarkers (Robinson et al., 2007).  
Various studies on H. pylori genome had suggested that the DNA of the species is 
extremely diverse, leading to differences in genotypes and phenotypes. This, in addition 
to genetic physiology and immunological factors in various combinations in human host, 
will thus likely cause varying infection outcomes (Proenca Modena et al., 2007). So, it is 
very important to understand how these various factors play a role in eliciting and 
causing disease in human host and its impact on the outcome of infection. Since proteins 
and antigens are the main cause of the disease and infection, it is vital to understand the 
interaction of these proteins with the human host and further characterize them.   
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1.2 The taxonomy Helicobacter and morphology  
The genus Helicobacter belongs to the phylum Proteobacteria, class 
Epsilonproteobacteria, family Helicobacteraceae and order Campylobacterales (On, 2001; 
Windsor & O'Rourke, 2000). Helicobacter infection is not only limited exclusively to 
humans, however it was found in various mammalian animals including domestic 
animals such as swine, canine, sheep and etc. There are few reported studies on species 
other than H. pylori such as H. acinonychis (cheetah), H. bizzozeronii and H. canis 
(canine), H. felis (felines), H. trogantum (swine and sheep), H. bilis (mouse) and many 
other animals. In human, there are also different strains of Helicobacter bacterium 
isolated and reported through various studies, for instants H. pylori (gastric mucosa), H. 
cinaedi (feaces), H. pullorum (feaces), and a few unclassified strains such as R53 (gastric 
mucosa), and Helicobacter. sp. taxon 8 (feaces). However to what extent these strains of 
Helicobacter implicated in human disease  is still unknown (Mikkonen et al., 2004).  
 H. pylori is a spiral shape, gram negative bacterium, about 3 µm long with a 
diameter of about 0.5 µm and is microaerophilic (Olczak et al., 2002). Under the 
microscope, the bacterium appears to be a corkscrew shape bacterium with a spiral shape 
flagella attached at its rear end. This is partly why it is called “helicobacter” and the term 
pylori refers to their favorite fortress.  It has the ability to colonize and form a biofilm on 
the stomach epithelium tissues and cause an invasive infection. The bacterium is also 
capable of converting from a spiral, viable form to a possibly viable, but nonculturable 
coccoid form to favor its survival. The coccoid form is capable of adhering to gastric 
epithelia cells in vitro. 
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Figure 1: Microscopic appearance of Helicobacter pylori  
Source :http://sites.google.com/site/scienceprofonline/infectiousdiseasescausedbybacteria 
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1.3 Pathogenesis of infection 
A pathogen is distinguished from a non-harmful pathogen by focusing on its virulence 
factors. H. pylori’s ability to reside and persist for many years within a host is even 
more important than its ability to damage the host tissues. Most of the pathogenesis 
seen in H. pylori are due to strain virulence, the host  mechanism to the bacterium and 
not because of the toxicity mediated by the bacterium itself (Andersen et al., 1997). 
 
1.3.1 Virulence factors  
Virulence factors had been extensively studied in an effort to associate bacterial 
phenotype with specific manifestations of disease, and to explicate the mechanisms of 
pathogenesis. To date, there are vast arrays of virulence factors identified and reported 
through various studies and some are frequently associated with the most serious 
clinical outcomes. For instants, cag pathogenicity island (cag PAI) encodes a type IV 
secretion apparatus (Censini et al., 1996; Argent et al., 2008). The cagA gene encodes 
a protein (CagA) that is injected into the cytoplasm of the host cell and induces 
cellular morphological alterations, proliferation, adhesion and apoptosis. The cagPAI 
also contains a gene known as cagE or picB that encodes a secretory protein that is 
required for the induction of interleukin (IL)-8 production by epithelia cells (Proenca 
Modena et al., 2007). The polymorphism of CagA is also strongly associated with H. 
pylori pathogenicity. In recent study, it is found that the increase in number of EPIYA-
C fragments in the CagA gene will increase the risk of developing gastric cancer 
(Basso et al., 2008). Patients with CagA positive strains are generally found to have 
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more severe symptoms than patients infected with CagA negative strains (Umit et al., 
2009).    
 Another important virulence factor of H. pylori is a 95 kDa secreted protein 
denominated VacA that induces apoptosis partly by forming pores in the mitochondria 
membrane, thereby allowing the efflux of cytochrome C. This protein also forms pores 
in the cytoplasmic and vacuole membranes, increases the paracellular permeability 
and causes the vacuolization of host epithelia cells and produces immonosuppression 
by blocking antigen presentation to T cells and the maturation of macrophage 
phagosomes (Terebiznik et al., 2006). The signal sequence (s1a, s1b, s1c, s2) and/or 
the middle region (m1, m2) of VacA varies considerably among H. pylori strains and 
strains with the s1m1 genotype are more pathogenic (Blaser and Atherton, 2004). The 
presence of i1 or i2 “intermediate region” also greatly increases the risk of developing 
peptic ulcer in patients (Basso et al., 2008).  In a recent study, it is also found that both 
VacA and CagA  down regulates each other’s activity and allow interaction of the 
bacterium  with the gastric epithelia cells by preventing excessive damage (Argent et 
al., 2008).     
 Despite all the above significant discoveries, there are still a vast 
amount of true and hypothetical virulence factors that are widely published that plays 
either major or minor role in manifestation of disease which had not yet been 
extensively studied, such as neutrophil-activating protein (NapA),  and cochaperone 
HspA (GroES) (Kimmel et al., 2000) and etc. These virulence factors might have 
potential in predicting the manifestation of specific pathologies (Andersen and 
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Espersen, 1992), which could have significant diagnostic values, awaiting to be 
explore. 
 
1.3.2 H. pylori binding factors  
When H. pylori infects a host, it must have an ability to bind to the mucosa layer and 
gastric epithelium in order to establish an infection. But to date, the binding 
mechanism of the bacterium is still not fully understood. A variety of different binding 
sites are present on H. pylori, which enables the bacterium to bind to the receptors on 
the surface of the epithelium cells and hence, enabling H. pylori to bind to the surface 
of the stomach and start its colonization (Wadstrom et al., 1994). 
Some binding factors that have been reported are HSP-60 which has the ability to bind 
to human gastric carcinoma cells (MKN45) in vitro (Yamaguchi et al., 1997b); N- 
acetylneuraminyllactose- binding fibrillar haemagglutinin which  specifically binds to 
GM3 gangliosides and sulphatides on the surface of the host cells (Saitoh et al., 1991) 
and a laminin-binding factor (Valkonen et al., 1994). These indicate that the adhesion 
of H. pylori to human gastric epithelial cells might be multifunctional in disease 
development. Apart from that, the binding also ensure that H. pylori are not washed 
away with the peristaltic movement inside the stomach during digestion.  
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1.3.3 Motility of H. pylori 
H. pylori is a flagellated bacterium which have the ability of being motile. They can 
roam freely in the lumen of the stomach before binding to the epithelial cells and 
causing an infection (Eaton et al., 1991). Motility of the H. pylori bacterium is 
governed by two major flagella forming genes, flaA and flaB.  These genes encodes 
for flagellin subunits namely FlaA and FlaB, which are coexpressed in different 
amounts which makes up the functioning flagella of the bacterium (Josenhans et al., 
1995). H. pylori demonstrate high level of motility in animal models, even in highly 
viscous environment than other enteric bacteria, such as salmonellae or Escherichia 
coli (Hazell et al., 1986).   
 Ability of H. pylori to colonize and establish an infection greatly depends on its 
ability to be motile. Few animal models studies in relation to human had concluded 
that motility plays a major role in colonizing and persistence of the bacterium on the 
stomach epithelium, and hence, motility is considered as a virulence factor (Josenhans 
et al., 1995). 
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1.3.4 Urease activity of H. pylori  
Urease is one of the most important virulence factors of H. pylori. The marked urease 
activity of H. pylori gives the organism the ability to colonize the acidic environment 
of the stomach by providing an alkaline microenvironment. Urease was the first 
virulence factor of H. pylori used for diagnostic purposes in gastric pathology (Eaton 
et al., 1991). The urease catalyzes the degradation of urea to ammonia and bicarbonate. 
Ammonia alkalizes the environment, leading to neutralization of the acid fluid in the 
stomach, which enable the survival of the bacterium in the stomach (Hazell and Lee, 
1986). When the hydrochloric acid concentration in the stomach reduces due to urease 
activity, it will stimulate the bacterium to colonize, and hence enabling the H. pylori to 
survive in the gastric mucosa permanently and causes disease (Stingl and De Reuse, 
2005). Thus, urease is considered as an important virulence factor.  
H. pylori also has the ability to produce permanent factors such as IL-1which can 
prevent the secretion of hydrochloric acid from the stomach parietal cells (Saperas et 
al., 1990); thus lowers the acid concentration in the stomach that enables the survival 
of H. pylori cells during the early phase of colonization. This enables H. pylori to 
colonize easily at the first stage of the infection.  
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Figure 2: H. pylori invades epithelial cells of human host  
Source:http://upload.wikimedia.org/wikipedia/commons/thumb/d/db/H_pylori_ulcer_diagr
am.png/800px-H_pylori_ulcer_diagram.png 
H. pylori are able to attach to the epithelial cells of the stomach and duodenum which 
stops them from being washed out of the stomach. Once attached, the bacteria start to 
cause damage to the cells by secreting degradative enzymes, toxins and initiating a  
self-destructive immune response. 
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1.4 Mode of transmission of H. pylori  
There are several hypotheses on the mechanisms involved in the mode of transmission 
of H. pylori; along with the postulation that human being is one of the sources of H. 
pylori. One hypothesis is that pathogen should be produced from the human stomach 
and appeared in gastric juice, saliva or dental plaque so that it can be easily 
transmitted to others through various routes. There are many different modes of 
transmission of H. pylori which is not fully understand, and hence, further research 
and investigation is needed to verify the actual path of dissemination of H. pylori 
(Malaty, 2007).   
 
1.4.1 Transmission through direct contact 
Human seems to be the only reservoir of H. pylori which spread from person to person 
via oral-oral, fecal-oral or gastro-oral routes (Kim et al., 2000). Various studies had 
demonstrated that H. pylori is present on human dental plaque (Li et al., 1996) which 
suggest that the prevalence of this bacterium is high in human’s saliva and it is spread 
via oral to oral route through various activities such as kissing, during meals and so on. 
But various investigators have found the organism with greater or lesser frequency in 
oral samples in different studies (Leimola-Virtanen et al., 1995). There is also a report 
stating that the oral cavity acts as a permanent reservoir for H. pylori (Leung et al., 
1999b).  As for fecal-oral route, both H. pylori bacterium and DNA are detected in 
stool culture and PCR respectively. However, the sensitivity for detection of H. pylori 
in stool is low in comparison with direct histological staining and culture of biopsy 
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samples (Kolho et al., 2006), yet there is still no solid scientific explanation why in 
certain cases, H. pylori DNA is detected in fecal material while the gastric biopsy 
sample was negative for culture, histological stain and PCR (Li et al., 1996). 
 
1.4.2 Waterborne transmission 
H. pylori is also known to be transmitted through water, due to fecal contamination, 
and this might be an important source of infection, especially in parts of the world in 
which untreated water is frequently consumed (West et al., 1990). And some research 
findings concluded that children who use external water sources have 3 times higher 
risk than children who consume treated water (Klein et al., 1991). However, H. pylori 
was also reported to be found in treated tap water (Fan et al., 1998).  The use of 
municipal water has also correlated with H. pylori infection in populations from both 
low and high socioeconomic status. In addition, swimming in stream water in the rural 
area of most of the developing country also increased the rate of infection of H. pylori 
(Lu et al., 2002). More studies should be carried out to further shed light on this mode 
of transmission.  
 
1.4.3 Transmission of H. pylori through animals  
Besides human, H. pylori also have been isolated from other animals. H. pylori 
isolated from domestic animals such as cats, dogs and sheep have been widely 
reported (Benoit et al., 2004; Eaton et al., 1991; Hanninen et al., 1995; Harbour and 
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Sutton, 2008; Quaglia et al., 2007). However there is no solid evidence on the 
transmission of H. pylori from animals to humans are imminent.  The most recent 
reservoir suggested for H. pylori is housefly (Brown et al., 2001). However, evidence 
is lacking that H. pylori can be transmitted to human from flies that have been on 
contact with H. pylori-infected feces. Nevertheless, the hypothesis is appealing since 
flies are known to carry many other infectious diseases. 
 
1.5 Gastric pathologies and associated diseases  
1.5.1 Gastric pathologies  
H. pylori is commonly associated with gastric pathologies such as peptic ulcer 
diseases (PUD) which includes gastric, gastric ulcer (GU), duodenal ulcer (DU), 
atrophic gastritis, gastric cancer (GC) and mucosa-associated lymphoid tissue 
lymphoma (Blaser, 1998). The strong relationship between H. pylori infection and 
peptic ulcer diseases has been studied and proven extensively, and is accepted that the 
organism is the major causative agent but not the only cause behind these diseases 
globally (Blaser and Atherton, 2004). By eradicating the bacterium in the stomach, it 
can alter the natural course of peptic ulcer disease by drastically reducing its 
recurrence rate in treated patients, as compared to untreated patients (Delaney et al., 
2008).   
 The mechanism by which H. pylori induces peptic ulcer disease (PUD) is 
incompletely understood but various findings suggested that the development of the 
disease involves a combination of genetic predisposition of the host, virulence factors 
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of the organism such as CagA and VacA, mechanical damage to the mucosa which is 
cause by unhealthy habits such as drinking and smoking, and finally, the alterations of 
gastric duodenal secretions (Giannakis et al., 2008; Kandulski et al., 2008; Love, 2008; 
Proenca Modena et al., 2007). Usually, when H. pylori invades stomach, it will 
express an active form of vacuolating cytotoxin (VacA) and a protein secretory 
apparatus called Cag (cytotoxin-associated gene products) that stimulates the host 
inflammatory responses (Viala et al., 2004).  Cag + strains interact more closely with 
epithelial cells and induce release of pro-inflammatory cytokines, and thereby increase 
inflammation (Kandulski et al., 2008).  
 H. pylori is a genetically diverse organism. The genetic variation of the 
organism differs from strain to strain and from region to region, and there are no 
absolute standards stating that certain strains are more ‘ulcerogenic’ than other strains, 
since other factors such as host and environment played important roles as well in the 
infection outcome (Majewski and Goodwin, 1988). 
 
1.5.2 Non-ulcer dyspepsia  
Non-ulcer dyspepsia comprises of a collection of assorted symptoms, including ulcer-
like and reflux-like symptoms. There are numerous causes suggested for non-ulcer 
dyspepsia, including lifestyle factors, stress, altered visceral sensation, increase 
serotonin sensitivity, alterations in gastric acid secretion, gastric emptying, and H. 
pylori infection (Veldhuyzen van Zanten and Sherman, 1994).  A recent review also 
highlighted the role played by psychosocial impairment in patients with non-ulcer 
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dyspepsia (Monteiro et al., 2001a). In a study linking H. pylori infection to non-ulcer 
dyspepsia, patients with the latter condition were twice as likely to be positive for the 
organism (Armstrong, 1996). Eradication of H. pylori cannot be considered as the 
standard of care in all patients with non-ulcer dyspepsia, because H. pylori infection is 
only one of the multifactorial etiologies of the disease manifestation.  
 
1.6 Epidemiology  
H. pylori is a common pathogenic bacterium infecting more than half of the world’s 
population (Moayyedi, 2007). Human stomach, and oral cavity are said to be the 
biggest reservoir of the bacterium, and the transmission probably occurs via person-to-
person route (Malaty, 2007).  In developing countries, the prevalence rate of the 
bacterium is considerably much higher in comparison with developed first world 
countries. Within these regions, subgroups are found to have higher prevalence rate in 
comparison to the general population, and it is greatly affected by the variations in age, 
socioeconomic status, ethnic backgrounds and geographical location (Nowottny and 
Heilmann, 1990). 
 Recent findings show that there is a decreasing trend of prevalence in those 
countries with rapidly improving socioeconomic conditions and developed countries. 
As for developing Asian countries, the prevalence of H. pylori are declining as shown 
in both seroprevalence-based and endoscopy based studies (Goh, 1997). This 
condition is also observed in other regions globally as well, like North America, 
Western Europe and Korea (Torres, 2000). Despite the decrease in prevalence, there 
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has been an increase in gastric cancer in Asia (Leung et al., 2008) and this 
phenomenon had been carefully monitored to study the relationship between the 
decreasing prevalence and incidences of gastric cancer. A numbers of convincing 
findings carried out in that region confirmed that age is an important factor for 
susceptibility towards gastric cancer, and the rate of developing gastric cancer appears 
to be higher in developing countries than in developed countries (Giannakis et al., 
2008; Kuipers et al., 1993a; Kuipers et al., 1993b) 
 The risk of an individual for developing chronic diseases associated with H. 
pylori varies; many case studies have discovered that, the risk increases significantly 
during childhood and the infection shows variatiosn among adults. Fundamentally, the 
infection of H. pylori occurs in early childhood (Das and Paul, 2007).  Childhood risk 
factors that are important includes contaminated and uncooked vegetables, 
contaminated water delivery systems, mother breastfeeding with saliva-coated nipples, 
poor hygiene, sharing beds during childhood and pre-mastication of food by mother 
for their children (Frenck and Clemens, 2003; Ahmed et al., 2009). Hence, the related 
factors above explain why such increases in infection are inevitable due to certain 
lifestyle practices.   
  In northern peninsular Malaysia, there are relatively low prevalence rate of H. 
pylori among the population. It is postulated that the genetic inheritance where by the 
gene from infected host passed on to the next generation will prolong H. pylori 
associated diseases. The Chinese and Indian communities are originally immigrant 
races that may have brought the infection over from their home countries to Malaysia 
(Li et al., 1991). Besides that, it is also found that the prevalence of H. pylori infection 
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also increased with age across all ethnic groups and gender. Based on a previously 
published study, the Indian, Chinese and Bangladeshi community are found to have 
higher prevalence of H. pylori during their childhood as compared to the local Malay 
community (Uyub et al., 1994), and the main contributing factors reported were 
contaminated food via non hygienic means and different lifestyle practiced by the 
different ethnic groups.  Besides that, the prevalence of H. pylori is also found to vary 
among different geographical regions in the same country. A study has documented 
different prevalence in H. pylori in northern peninsular Malaysia and one of the main 
contributing factors was the poor and unhygienic environment condition (Sasidharan 
et al., 2008; Uyub et al., 1994).  
 In addition, the infection of H. pylori acquired in childhood can lead to 
multifocal gastritis and the patients are thus predisposed to various gastric symptoms 
later in life (Rocha et al., 2003). The main causative factors for childhood exposure are 
in developing countries includes poor water supply system, poor sewage treatment and 
disposal and other unhygienic environmental conditions affecting those with low socio 
economic status (Ahmed et al., 2007). Senior citizen above the age of 50 are the most 
infected with H. pylori and such condition can be correlated with the lifestyle of 
Malaysians 50 years ago and they developed symptoms only later in life as the 
bacterium will need time to manifest the symptoms of the infection (Khan, 1998).  
However, the population of the new generation has benefited from the improvements 
in economics and hygienic levels of the country; this had led to the reduction in the 
prevalence rate of H. pylori among youngsters. It was reported that the seroprevalence 
rate among children had fallen drastically (10.3%) as compared to adults (50%) (Boey 
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et al., 1999) and it is believed that the improvement of life style and hygienic level is 
the main contributing factors behind this development. Similar studies performed in 
Malaysia (Raj et al., 2001) and Singapore (Kang et al., 1990; Vu and Ng, 2000) show 
that there are significant differences in ratio of prevalence of H. pylori with respective 
age group across all ethnics and gender. But in certain cases, age related physiological 
changes also may predispose the individual to the infection (Parsonnet et al., 1988). 
Essentially, in a multi-racial community, socioeconomic and social-cultural practices 
are being associated to the relative difference in prevalence of the bacterium (Ahmed 
et al., 2007). 
 In Europe, the estimated incidences of infection at childhood the age of 10 are 
considerably high, around 50% of the children were found to be infected with H. 
pylori. The risk factors are similar with those identified in Asian countries, ranging 
from contaminated food, water source and low socioeconomic status (Torres, 2000).  
Transmission from parent to child has also been implicated and in some cases (Rocha 
et al., 2003),  child-to-child transmission was also observed (Goodman and Correa, 
2000). Thus, it shows that transmission is common among people with close 
relationships.  
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1.7 Diagnosis of H. pylori  
To date, many diagnostic methods have been developed for screening of H. pylori in 
patients. The samples are obtained from the patients via both invasive and non 
invasive methods; each has their advantages and disadvantage, taking into 
consideration factors such as ethics, feasibility, economy and accuracy of the 
diagnostic tests. Many diagnostic tests has been used for detecting H. pylori in patients, 
but over the years, more diagnostic methods have been developed which give better 
accuracy.  
 
1.7.1 Invasive test 
Conventionally, invasive test has been employed by physicians to diagnose H. pylori 
infection in patients through endoscopy. The biopsy taken from the stomach epithelia 
by means of endoscopy was used on various diagnosis procedures to detect the 
presence of the bacterium in  patients (Rautelin et al., 2003). There are a few types of 
invasive methods that are widely employed in medical field they are namely, 
histopathology examination, culture and rapid urease test (Zuniga-Noriega et al., 
2006).  Histopathology staining remains one of the best methods for detection H. 
pylori infection, and together with the visual observation by endoscopy; it provide a 
consortium of information based on the pathological condition of the stomach 
(Makristathis et al., 2004). However endoscopy is considered as expensive, unpleasant 
for patients and need highly specialized and experienced endoscopists to perform, in 
some cases, endoscopy is too expensive to be performed as a routine diagnosis for 
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gastric patients. Sampling error may also occur and causes false-negative results 
(Mitchell and Megraud, 2002) that can lead to inaccurate diagnosis.   
 A recent study has found that rapid urease test is able to provide a fast and 
simple diagnosis, with high specificity, and relatively low cost (Zuniga-Noriega et al., 
2006). The procedure is performed by placing a single biopsy specimen in a test vial 
containing rapid urease test solution, incubate at 37°C overnight and observe for 
conversion of colors, from yellow to pink, which is conclude as a positive test. The 
method is the most time efficient and  cheap to used in routine diagnosis procedures 
(Yousfi et al., 1996).  
 Culture is one of the options for detecting the presence of H. pylori. This 
method is rather difficult as it requires tedious and demanding culture techniques, with 
many factors that must be controlled, as compared to other methods. Culture needs 
specialized conditions for specimen transportation and speed in processing of the 
samples to increase the probability of recovering the organism. The media used are 
rather expensive, coupled with special conditions for maintenance, and the length of 
time necessary to obtain a culture result is slow compared to other methods  (Perez-
Perez, 2000).  However, one of the advantages of culture diagnosis is antibiotic 
susceptibility test; this test can be performed in cases of antibiotic resistance 
(Wadstrom et al., 1994). 
 PCR is also sometimes used in diagnosis of H. pylori. This method can either 
be invasive or non invasive, depends on the samples use. This method has been used 
successfully to detect the presence of H. pylori in biopsy specimens, water and feces 
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with sensitive, specific results with short period of time (Monteiro et al., 2001b; Lage 
et al., 1995; Brooks et al., 2004). But one of disadvantage is the need of specialized 
personal to perform the test.    
 
1.7.2 Non-invasive test 
As for non-invasive test, there are also a few well-recognized methods employed 
widely in diagnosis of H. pylori infection, which include serology and carbon-labeled 
urea breath test. The presence of antibodies specific towards H .pylori in serum, whole 
blood and saliva is tested using serological methods like ELISA and western blotting 
(Alkout et al., 1997; Faulde et al., 1991; Kimmel et al., 2000). Even though serology 
test gives high sensitivity and specificity towards H. pylori, but may not discriminate 
between asymptomatic, active or chronic infection and past infection due to 
persistence of circulating antibodies to H. pylori in the body (Blanco et al., 2008). 
These antibodies usually remain detectable in human body after successful eradication.  
 Urease breath test is a non-invasive test based on metabolism of ingested 
labeled urea to labeled carbon dioxide, and it is a highly predictive method for 
diagnosis of H. pylori infection. It is very useful for detection of active infection, 
however, false negative results are possible if patients have undergone recent 
treatment, but a valid urease breath test can be performed a week after discontinuing 
therapy (Monteiro et al., 2001a).  
 PCR is another alternative for non-invasive test which is used to detect the 
presence of H. pylori DNA in human samples like saliva, dental plaque and feces that 
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is capable of providing accurate results in a relatively short period of time (Monteiro 
et al., 2001b; Lage et al., 1995; Li et al., 1996).  
 
1.8 Diagnostic markers  
Currently, there are various diagnostic markers reported for H. pylori infection. These 
markers, some are commercialized, give great advantages in detecting and diagnosing 
H. pylori infection in patients.   
 The accuracy of these markers varies from test to test, depending greatly on 
type of sample and type of assay, thus some are no longer adequate to justify their use 
based on both clinical and economical aspects (Vaira and Vakil, 2001).  However, 
there is a new range of markers that had been made into commercialized diagnostic 
kits and provide better efficiency in terms of both accuracy and economy. Diagnostic 
kits that utilize stool antigen and carbon labeled urease breath test (Manes et al., 2001a; 
Manes et al., 2001b) have opened new options in diagnosis of active H. pylori 
infection. It is suggested that these kits should replace serological test particularly in 
test and treatment strategies currently being recommended in clinical practices (Vaira 
and Vakil, 2001).     
 There are two types of markers used in diagnosing H. pylori infection. They 
comprise of DNA and protein markers. DNA markers are detected by the means of 
PCR and will give very sensitive results. PCR are done on samples such as tissue 
biopsy samples, stool and gastric juice, and PCR proves to have a good sensitivity and 
specificity towards all types of samples (Lage et al., 1995), but routine use of PCR for 
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diagnosis has also been proven to be problematic as inhibition is inevitable in certain 
samples such as stool (el-Zaatari et al., 1995; el-Zaatari et al., 1997), and if other 
bacterium contains homologous sequences, it will yield false-positive results, hence 
lowering its specificity (Sugimoto et al., 2009).. Despite all the disadvantages, PCR 
remains as a promising tool that enables the detection of antimicrobial resistance by 
detecting mutations correlated with various antibiotics (Sevin et al., 1998). Currently, 
PCR remains a research tool for diagnosing H. pylori infection.  
Protein diagnostic markers are mainly detected by the means of serological testing. 
There are numerous immunoassays developed for detection of anti-H. pylori IgG, IgA 
and IgM antibodies produced during the course of infection. These antibodies can be 
detected using whole blood, serum, saliva, stool and urine (Manes et al., 2005; 
Sasidharan and Uyub, 2009a; Faulde et al., 1991; Miwa et al., 2001; Simor et al., 
1996). The two most developed methods such as immunoblotting (Aucher et al., 1998; 
Haas et al., 2002; Keenan et al., 2000) and ELISA (Rautelin et al., 2003; Simor et al., 
1996; Uyub et al., 1994) are widely used in clinical research. Detection of H. pylori 
infection markers via serology method is the easiest non-invasive approach to 
diagnose this infection, with some test requires only a few drops of blood from the 
finger and the results are available in less than 5 minutes. However serological 
diagnosis is still not well recognized because of the prevalence of H. pylori antibodies 
post-treatment (Rosenstock et al., 2000).  
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1.8.1 DNA markers for H. pylori 
Various diagnostic markers have been discovered and used widely in clinical 
diagnosis and research of H. pylori. These markers focus mainly on the virulence 
factors of the pathogen. Diagnostic markers such as vacA encodes for a vacuolating 
cytotoxin that induces apoptosis in epithelia cells (de Bernard et al., 2004); while cagA 
codes for a cytotoxin A that promotes the alteration of cellular membrane and 
apoptosis of the epithelia cells (Shmuely et al., 2005; Censini et al., 1996). Other 
genes such as iceA and ureC (Chomvarin et al., 2008) are also routinely used to screen 
the presence of H. pylori infection in a patient. However, the most popular DNA 
diagnostic markers are cagA, vacA and ureC. These genes are routinely used both in 
clinical and lab for diagnostic purposes from clinical samples such as blood, biopsy 
tissues, feces, saliva, whole blood and cultures (Chisholm and Owen, 2008; Monteiro 
et al., 2001b; Brooks et al., 2004; Kim et al., 2000; Li et al., 1996).  However, the 
specificity and sensitivity of the diagnosis varies, according to different sample 
preparations and various laboratory conditions (Sugimoto et al., 2009).  
On the market, there are very few commercial DNA based diagnostic kits 
available for H. pylori, most of the tests are performed in specialized laboratories with 
trained personals, since the assay is prone to contamination without proper handling 
and facilities (el-Zaatari et al., 1997). Requirement for cold chain transport makes it 
not accessible to developing countries, hence, DNA based diagnostic of H. pylori is 
not as popular as protein based diagnostic kits.  
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1.8.2 Protein markers for H. pylori  
Protein based markers are very popular compared to DNA based markers, as it is 
manufactured into cheap user friendly forms, such as immobilized strips. Besides that, 
protein based diagnostic kits are also available in ELISA and latex agglutination test 
cards.  Immunoblotting is also performed as a lab-based serological method. These 
assays detect anti-H. pylori antibodies in either fecal, whole blood, serum, urine, and 
stool (Sasidharan and Uyub, 2009a; Zuniga-Noriega et al., 2006; Simor et al., 1996; 
Glassman et al., 1990; Miwa et al., 2001).  
 In serology studies, various H. pylori proteins had been employed as infection 
markers for diagnosis. Markers such as CagA, VacA, HspB, FlaA, FlaB, UreC are 
most commonly used (Cremonini et al., 2004; Schumann et al., 2006).  In addition, 
there are also several unidentified proteins such as 18, 39.5, 33 34 kDa which were 
reported to be of potential diagnostic values (Galmiche et al., 2000; Keenan et al., 
2000; Andersen and Espersen, 1992; Haas et al., 2002).     
 Lately, there is also another array of markers that not only act as diagnosis 
markers, it can also be used to predict the outcome of the infection. For instance, heat 
shock protein 60 (HSP-60) is associated with adhesion of the H. pylori cells onto the 
epithelial cells, which can further accelerate the infection process of H. pylori 
(Yamaguchi et al., 1997a).  CagA was also used to determine the relation between H. 
pylori infection and gastric cancer. If the gastric cancer patients was positive for IgG 
against CagA, H. pylori is probably the main cause of gastric cancer, hence, strains 
which are CagA+ are more pathogenic compared to CagA- strains. Therefore, more 
attention should be focused on eradication CagA+ strains in patients to prevent further 
